drugset / Trial / NCT04045821
Endometrial Rejuvenation Study
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the response of the endometrial lining after subcutaneous administration of the medication AMD3100. This medication mobilizes stem cells and will be used in a population of infertile women with a thin endometrium who are undergoing frozen-thawed embryo transfer. The investigators will assess associations between response to stem cell mobilization and pregnancy outcomes.
Timeline
- Start
- 2020-01-17
- Primary completion
- 2021-01-27
- Completion
- 2021-05-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AMD3100 | Small molecule | 0.24 mg/kg | Subcutaneous |